Insider · CIK 0001504224
John Alexander Martin
Files at EPIX (ESSA Pharma Inc.). First filing -, latest -.
John Alexander Martin files SEC Form 4 as director at EPIX (ESSA Pharma Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Alexander Martin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | EPIX ESSA Pharma Inc. | DDisposition to issuer Common Shares | -14,299 | - | - | 0 | Oct 15, 2025 |
Questions about John Alexander Martin
Answered from the filings on this page, as of the latest one.
Is John Alexander Martin buying or selling?
John Alexander Martin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Alexander Martin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Alexander Martin has 0.
Where does John Alexander Martin file Form 4?
John Alexander Martin has filed Form 4 at EPIX (ESSA Pharma Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.